Skip to main content

New methods based on capillary electrophoresis for in vitro evaluation of protein tau phosphorylation by glycogen synthase kinase 3-β

Abstract

The hyperphosphorylation of tau protein is associated with the development of the neuronal pathology of Alzheimer’s disease. As most conventional methods study only particular phosphorylation sites of tau, it is necessary to develop a simple and reliable assay to determine the phosphorylation of tau at multiple sites. Capillary electrophoresis (CE)-based enzymatic assays are not yet used to monitor tau phosphorylation. The present work aims to develop CE-based assays to evaluate tau phosphorylation by the glycogen synthase kinase 3-β (GSK3β). A novel pre-capillary CE assay was first developed. An in-capillary CE-based enzymatic assay was also used since this approach is known to be time- and cost- effective. The enzymatic reaction was monitored by quantifying the product adenosine 5′- diphosphate (ADP). The influence of two classes of glycosaminoglycan (GAG), namely heparin and heparan sulfate, on the phosphorylation reaction was also assessed. Results obtained by both CE approaches were comparable and in excellent agreement with those reported in the literature using conventional radiometric and immunoblotting methods. In fact, CE results confirmed the inductory effect of the sulfated sugars heparin and heparan sulfate on tau hyperphosphorylation, probably because of the exposition of new sites phosphorylatable by GSK3β. This study shows that simple (no-labeling), rapid (less than 30 min per assay), and eco-friendly (no-radioactivity) CE-based kinase assays can give insight into the abnormal phosphorylation of tau. They can be extended to screen different modulators of tau phosphorylation to highlight their function and to develop effective drugs for neurodegenerative disease treatments.

On-line capillary electrophoresis for the evaluation of glycosaminoglycan (GAG) influence on the phosphorylation of tau protein by GSK3b

This is a preview of subscription content, access via your institution.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

References

  1. Noble W, Hanger DP, Miller CC, Lovestone S (2013) The importance of tau phosphorylation for neurodegenerative diseases. Front Neurol 4(83):1–11

  2. Wang J-Z, Xia Y-Y, Grundke-Iqbal I, Iqbal K (2013) Abnormal hyperphosphorylation of tau: sites, regulation, and molecular mechanism of neurofibrillary degeneration. J Alzheimers Dis 33:S123–S139

    Google Scholar 

  3. Goedert M, Hasegawa M, Jakes R, Lawler S, Cuenda A, Cohen P (1997) Phosphorylation of microtubule-associated protein tau by stress-activated protein kinases. FEBS Lett 409(1):57–62

    Article  CAS  Google Scholar 

  4. Paudel HK, Li W (1999) Heparin-induced conformational change in microtubule-associated protein tau as detected by chemical cross-linking and phosphopeptide mapping. J Biol Chem 274(12):8029–8038

    Article  CAS  Google Scholar 

  5. Hanger DP, Byers HL, Wray S, Leung K-Y, Saxton MJ, Seereeram A et al (2007) Novel phosphorylation sites in tau from Alzheimer brain support a role for casein kinase 1 in disease pathogenesis. J Biol Chem 282(32):23645–23654

    Article  CAS  Google Scholar 

  6. Kang T, Kim J, Hong I, Park N, Heinsen H, Lee J-Y et al (2014) Large-scale analysis of post-translational modifications in the hippocampus of patients with Alzheimer’s disease using pI shift and label-free quantification without enrichment. Anal Bioanal Chem 406(22):5433–5446

    Article  CAS  Google Scholar 

  7. Zeller M, König S (2004) The impact of chromatography and mass spectrometry on the analysis of protein phosphorylation sites. Anal Bioanal Chem 378(4):898–909

  8. Grundke-Iqbal I, Iqbal K, Tung YC, Quinlan M, Wisniewski HM, Binder LI (1986) Abnormal phosphorylation of the microtubule-associated protein tau (tau) in Alzheimer cytoskeletal pathology. Proc Natl Acad Sci U S A 83(13):4913–4917

    Article  CAS  Google Scholar 

  9. Hashiguchi M, Hashiguchi T (2013) Kinase–kinase interaction and modulation of tau phosphorylation. In: Kwang WJ (ed) International review of cell and molecular biology, vol 300, chap 4. Academic Press, Knoxville, p 121–160

  10. Zheng-Fischhöfer Q, Biernat J, Mandelkow E-M, Illenberger S, Godemann R, Mandelkow E (1998) Sequential phosphorylation of tau by glycogen synthase kinase-3β and protein kinase A at Thr212 and Ser214 generates the Alzheimer-specific epitope of antibody AT100 and requires a paired-helical-filament-like conformation. Eur J Biochem 252(3):542–552

    Article  Google Scholar 

  11. Sibille N, Sillen A, Leroy A, Wieruszeski J-M, Mulloy B, Landrieu I et al (2006) Structural impact of heparin binding to full-length tau as studied by NMR spectroscopy. Biochemistry 45(41):12560–12572

    Article  CAS  Google Scholar 

  12. Hasegawa M, Crowther RA, Jakes R, Goedert M (1997) Alzheimer-like changes in microtubule-associated protein tau induced by sulfated glycosaminoglycans: inhibition of microtubule binding, stimulation of phosphorylation, and filament assembly depend on the degree of sulfation. J Biol Chem 272(52):33118–33124

    Article  CAS  Google Scholar 

  13. Nehmé H, Nehmé R, Lafite P, Routier S, Morin P (2013) Human protein kinase inhibitor sceening by capillary electrophoresis using transverse diffusion of laminar flow profiles for reactant mixing. J Chromatogr A 1314:298–305

    Article  Google Scholar 

  14. Nehmé H, Nehmé R, Lafite P, Routier S, Morin P (2013) In-capillary reactant mixing for monitoring glycerol kinase kinetics by CE. J Sep Sci 36(13):2151–2157

    Article  Google Scholar 

  15. Bohoyo D, Le Potier I, Riviere C, Klafki H, Wiltfang J, Taverna M (2010) A quantitative CE method to analyse tau protein isoforms using coated fused silica capillaries. J Sep Sci 33(8):1090–1098

    CAS  Google Scholar 

  16. Llorens-Marítin M, Jurado J, Hernández F, Ávila J (2014) GSK-3β, a pivotal kinase in Alzheimer disease. Front Mol Neurosci 46(7):1–11

  17. Noh M-Y, Chun K, Kang BY, Kim H, Park J-S, Lee H-C et al (2013) Newly developed glycogen synthase kinase-3 (GSK-3) inhibitors protect neuronal cells death in amyloid-beta induced cell model and in a transgenic mouse model of Alzheimer’s disease. Biochem Biophys Res Commun 435(2):274–281

    Article  CAS  Google Scholar 

  18. Onishi T, Iwashita H, Uno Y, Kunitomo J, Saitoh M, Kimura E et al (2011) A novel glycogen synthase kinase-3 inhibitor 2-methyl-5-(3-{4-[(S )-methylsulfinyl]phenyl}-1-benzofuran-5-yl)-1,3,4-oxadiazole decreases tau phosphorylation and ameliorates cognitive deficits in a transgenic model of Alzheimer’s disease. J Neurochem 119(6):1330–1340

    Article  CAS  Google Scholar 

  19. del Ser T, Steinwachs KC, Gertz HJ, Andrés MV, Gómez-Carrillo B, Medina M et al (2013) Treatment of Alzheimer’s disease with the GSK-3 inhibitor tideglusib: a pilot study. J Alzheimers Dis 33(1):205–215

    Google Scholar 

  20. Hai X, Yang B-f, Van Schepdael A (2012) Recent developments and applications of EMMA in enzymatic and derivatization reactions. Electrophoresis 33(1):211–227

    Article  CAS  Google Scholar 

  21. Shanmuganathan M, Britz-McKibbin P (2013) High quality drug screening by capillary electrophoresis: a review. Anal Chim Acta 773:24–36

    Article  CAS  Google Scholar 

  22. Nehmé H, Nehmé R, Lafite P, Routier S, Morin P (2012) New development in in-capillary electrophoresis techniques for kinetic and inhibition study of enzymes. Anal Chim Acta 722:127–135

    Article  Google Scholar 

  23. Krylova SM, Okhonin V, Evenhuis CJ, Krylov SN (2009) The inject-mix-react-separate-and-quantitate (IMReSQ) approach to studying reactions in capillaries. Trends Anal Chem 28(8):987–1010

    Article  CAS  Google Scholar 

  24. Nehmé R, Perrin C, Cottet H, Blanchin MD, Fabre H (2008) Influence of polyelectrolyte coating conditions on capillary coating stability and separation efficiency in capillary electrophoresis. Electrophoresis 29(14):3013–3023

    Article  Google Scholar 

  25. Nehmé R, Perrin C, Cottet H, Blanchin M-D, Fabre H (2009) Influence of polyelectrolyte capillary coating conditions on protein analysis in CE. Electrophoresis 30(11):1888–1898

    Article  Google Scholar 

  26. Nehmé R, Nehmé H, Roux G, Destandau E, Claude B, Morin P (2013) Capillary electrophoresis as a novel technique for screening novel flavonoids as kinases inhibitors. J Chromatogr A 1318:257–264

    Article  Google Scholar 

  27. Lovestone S, Reynolds CH, Latimer D, Davis DR, Anderton BH, Gallo J-M et al (1994) Alzheimer’s disease-like phosphorylation of the microtubule-associated protein tau by glycogen synthase kinase-3 in transfected mammalian cells. Curr Biol 4(12):1077–1086

    Article  CAS  Google Scholar 

  28. Fan Y, Scriba GKE (2010) Advances in-capillary electrophoretic enzyme assays. J Pharm Biomed Anal 53(5):1076–1090

    Article  CAS  Google Scholar 

  29. Kaiser TJ, Thompson JW, Mellors JS, Jorgenson JW (2009) Capillary-based instrument for the simultaneous measurement of solution viscosity and solute diffusion coefficient at pressures up to 2000 bar and implications for ultrahigh pressure liquid chromatography. Anal Chem 81:2860–2868

    Article  CAS  Google Scholar 

  30. Arrio-Dupont M, Cribier S, Foucault G, Devaux PF, Albis A (1996) Diffusion of fluorescently labeled macromolecules in cultured muscle cells. Biophys J 70:2327–2332

    Article  CAS  Google Scholar 

Download references

Author information

Affiliations

Authors

Corresponding authors

Correspondence to Dulce Papy-Garcia or Reine Nehmé.

Electronic supplementary material

Below is the link to the electronic supplementary material.

ESM 1

(PDF 371 kb)

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Nehmé, H., Chantepie, S., Defert, J. et al. New methods based on capillary electrophoresis for in vitro evaluation of protein tau phosphorylation by glycogen synthase kinase 3-β. Anal Bioanal Chem 407, 2821–2828 (2015). https://doi.org/10.1007/s00216-015-8495-7

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00216-015-8495-7

Keywords

  • Protein tau
  • Glycogen synthase kinase-3β (GSK3β)
  • Heparan sulfates
  • Heparin
  • Transverse diffusion of laminar flow profiles (TDLFP)